Detalles de la búsqueda
1.
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Nature
; 603(7903): 942-948, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35322232
2.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
N Engl J Med
; 384(13): 1191-1203, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33789008
3.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Future Oncol
; 19(11): 739-752, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36919706
4.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet
; 398(10294): 27-40, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34102137
5.
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens.
BMC Cancer
; 20(1): 633, 2020 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641104
6.
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study.
J Clin Oncol
; 42(17): 2080-2093, 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38723227
7.
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial.
J Thorac Oncol
; 17(2): 289-308, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648948
8.
The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].
PLoS One
; 15(3): e0229900, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32142532
9.
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Eur J Cancer
; 116: 137-147, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31195357
10.
Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine.
Trials
; 19(1): 695, 2018 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30572928
11.
Chemotherapy induced nausea and vomiting--prevention and treatment.
Aust Fam Physician
; 36(9): 702-6, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17885702
12.
Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy.
BMJ Open
; 7(5): e014458, 2017 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28559456
13.
Positive sentinel lymph node metastasis from a metastasis in Melanoma.
Asia Pac J Clin Oncol
; 10(4): 376-7, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24456240
14.
Audit of patients with mesothelioma treated with pemetrexed in a single institution in Western Australia.
Asia Pac J Clin Oncol
; 6(4): 350-6, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21114785
15.
Outbreak of sporotrichosis, Western Australia.
Emerg Infect Dis
; 13(8): 1228-31, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17953099
16.
Epidemiological features and control of an outbreak of scarlet fever in a Perth primary school.
Commun Dis Intell Q Rep
; 29(4): 386-90, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16465930
17.
Reactive arthritis and vasculitis in a child due to Ross River virus infection.
Med J Aust
; 181(11-12): 710, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15588219
Resultados
1 -
17
de 17
1
Próxima >
>>